{"schema_version":"secwatch.filing_event.v1","accession":"0001639691-23-000025","form_type":"8-K","ticker":"LIVN","cik":"0001639691","company_name":"LivaNova PLC","filed_at":"2023-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.957464+00:00","generated_at":"2026-06-17T16:44:17.367741+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"LivaNova completes enrollment of 500th unipolar patient in RECOVER depression trial","bullets":["Independent committee advised enrollment to continue from 475 to 500 unipolar patients per protocol.","500th unipolar patient randomized on March 23, 2023; final analysis after 12-month follow-up data.","Trial evaluates Vagus Nerve Stimulation for difficult-to-treat depression; results to be published."],"urls":{"canonical":"https://secwatch.observer/filing/0001639691-23-000025","json":"https://secwatch.observer/filing/0001639691-23-000025.json","markdown":"https://secwatch.observer/filing/0001639691-23-000025.md","text":"https://secwatch.observer/filing/0001639691-23-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000025/0001639691-23-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000025/livn-20230322.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T16:44:17.367741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}